|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 295/08 | (2006.01) |
| A61K 31/4418 | (2006.01) | ||
| A61K 31/451 | (2006.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/14 | (2006.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07D 211/18 | (2006.01) | ||
| C07D 211/20 | (2006.01) | ||
| C07D 211/22 | (2006.01) | ||
| C07D 211/24 | (2006.01) | ||
| C07D 211/30 | (2006.01) | ||
| C07D 211/32 | (2006.01) | ||
| C07D 211/34 | (2006.01) | ||
| C07D 211/70 | (2006.01) | ||
| C07D 295/073 | (2006.01) | ||
| C07D 295/096 | (2006.01) | ||
| C07D 295/112 | (2006.01) | ||
| C07D 295/155 | (2006.01) | ||
| C07D 405/04 | (2006.01) | ||
| C07D 405/06 | (2006.01) |
| (11) | Number of the document | 1240141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00989161.5 |
| Date of filing the European patent application | 2000-12-22 | |
| (97) | Date of publication of the European application | 2002-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2003-11-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE0002/673 |
| Date | 2000-12-22 |
| (87) | Number | WO 0104/6144 |
| Date | 2001-06-28 |
| (30) | Number | Date | Country code |
| 9904724 | 1999-12-22 | SE |
| (72) |
ANDERSSON, Bengt DI, SE
SONESSON, Clas, SE
WATERS, Susanna, SE
WATERS, Nicholas, SE
TEDROFF, Joakim, SE
|
| (73) |
A. Carlsson Research AB,
Box 444, 405 30 Göteborg,
SE
|
| (54) | NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION |
| NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION |